Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/cotranslocation

被引:82
作者
Tie, JK
Nicchitta, C
von Heijne, G
Stafford, DW [1 ]
机构
[1] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA
[2] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA
[3] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden
关键词
D O I
10.1074/jbc.M500765200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin K epoxide reductase (VKOR) catalyzes the conversion of vitamin K 2,3-epoxide into vitamin K in the vitamin K redox cycle. Recently, the gene encoding the catalytic subunit of VKOR was identified as a 163-amino acid integral membrane protein. In this study we report the experimentally derived membrane topology of VKOR. Our results show that four hydrophobic regions predicted as the potential transmembrane domains in VKOR can individually insert across the endoplasmic reticulum membrane in vitro. However, in the intact enzyme there are only three transmembrane domains, residues 10 - 29, 101 - 123, and 127 - 149, and membrane-integration of residues 75 - 97 appears to be suppressed by the surrounding sequence. Results of N-linked glycosylation-tagged full-length VKOR shows that the N terminus of VKOR is located in the endoplasmic reticulum lumen, and the C terminus is located in the cytoplasm. Further evidence for this topological model of VKOR was obtained with freshly prepared intact microsomes from insect cells expressing HPC4-tagged full-length VKOR. In these experiments an HPC4 tag at the N terminus was protected from proteinase K digestion, whereas an HPC4 tag at the C terminus was susceptible. Altogether, our results suggest that VKOR is a type III membrane protein with three transmembrane domains, which agrees well with the prediction by the topology prediction program TMHMM.
引用
收藏
页码:16410 / 16416
页数:7
相关论文
共 39 条
[1]   Characterization and purification of the vitamin K1 2,3 epoxide reductase system from rat liver [J].
Begent, LA ;
Hill, AP ;
Steventon, GB ;
Hutt, AJ ;
Pallister, CJ ;
Cowell, DC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (04) :481-486
[2]  
BELL R G, 1970, Archives of Biochemistry and Biophysics, V141, P473, DOI 10.1016/0003-9861(70)90164-5
[3]   Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane [J].
Cain, D ;
Hutson, SM ;
Wallin, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29068-29075
[4]   Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid [J].
Furie, B ;
Bouchard, BA ;
Furie, BC .
BLOOD, 1999, 93 (06) :1798-1808
[5]   SEQUENCE DIFFERENCES BETWEEN GLYCOSYLATED AND NONGLYCOSYLATED ASN-X-THR SER ACCEPTOR SITES - IMPLICATIONS FOR PROTEIN ENGINEERING [J].
GAVEL, Y ;
VONHEIJNE, G .
PROTEIN ENGINEERING, 1990, 3 (05) :433-442
[6]   Topogenesis of membrane proteins: determinants and dynamics [J].
Goder, V ;
Spiess, M .
FEBS LETTERS, 2001, 504 (03) :87-93
[7]   Vitamin K epoxide reductase: homology, active site and catalytic mechanism [J].
Goodstadt, L ;
Ponting, CP .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (06) :289-292
[8]   The thioredoxin system - From science to clinic [J].
Gromer, S ;
Urig, S ;
Becker, K .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :40-89
[9]   Topology models for 37 Saccharomyces cerevisiae membrane proteins based on C-terminal reporter fusions and predictions [J].
Kim, H ;
Melén, K ;
von Heijne, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) :10208-10213
[10]   IDENTIFICATION OF A WARFARIN-SENSITIVE PROTEIN-COMPONENT IN A 200S RAT-LIVER MICROSOMAL FRACTION CATALYZING VITAMIN-K AND VITAMIN-K 2,3-EPOXIDE REDUCTION [J].
LEE, JJ ;
PRINCIPE, LM ;
FASCO, MJ .
BIOCHEMISTRY, 1985, 24 (25) :7063-7070